Risk-based prioritization of pharmaceuticals in the natural environment in Iraq, Environ Sci Pollut Res, vol.23, pp.15712-15726, 2016. ,
The Theriaque database and information on side effects of drugs, Therapie, vol.49, pp.455-459, 1994. ,
Emission factor estimation of ca. 160 emerging organic microcontaminants by inverse modeling in a Mediterranean river basin, Sci Total Environ, vol.520, pp.241-252, 2015. ,
The social amplification of risk and the hazard sequence: the October 1995 oral contraceptive pill scare, Health Risk Soc, vol.5, pp.301-313, 2003. ,
Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization, Hum Ecol Risk Assess, vol.14, pp.665-695, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00454514
Prioritising anticancer drugs for environmental monitoring and risk assessment purposes, Sci Total Environ, vol.473, pp.159-170, 2014. ,
Benefit/risk communication by the European Medicines Agency: a study of influential stakeholders' expectations and attitudes, 2011. ,
Are pharmaceuticals potent environmental pollutants? Part I: Environmental risk assessments of selected active pharmaceutical ingredients, Sci Total Environ, vol.364, pp.67-87, 2006. ,
A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals, Environ Toxicol Chem, vol.35, pp.1021-1027, 2014. ,
Exposure assessment tools and models. EPI Suite v4, vol.1, 2013. ,
, European Medicines Agency (EMA, 2006.
Ecotoxicology of human pharmaceuticals, Aquat Toxicol, vol.76, pp.122-159, 2006. ,
Predicted critical environmental concentrations for 500 pharmaceuticals, Regul Toxicol Pharmacol, vol.58, pp.516-523, 2010. ,
Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain), Environ Res, vol.138, pp.161-172, 2015. ,
Risk assessment of persistent pharmaceuticals in biosolids: dealing with uncertainty, J Hazard Mater, vol.302, pp.72-81, 2016. ,
Crisis as seen by the individual: the norm deviation approach/La crisis vista por el individuo: el Enfoque de la Desviación de la Norma, Psyecology, vol.6, pp.103-135, 2015. ,
Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry, Environ Sci Pollut Res, vol.19, pp.3210-3218, 2012. ,
Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry, Anal Bioanal Chem, vol.406, pp.3801-3814, 2014. ,
The significance of different health institutions and their respective contributions of active pharmaceutical ingredients to wastewater, Environ Internat, vol.85, pp.61-76, 2015. ,
Nanotechnology and society: the evolution of risk perceptions, Nat Nanotechnol, vol.4, pp.705-706, 2009. ,
Worldwide estimation of river concentrations of any chemical originating from sewage-treatment plants using dilution factors, Environ Toxicol Chem, vol.33, pp.447-452, 2014. ,
Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water, Environ Sci Pollut Res, vol.17, pp.486-496, 2010. ,
Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works, Environ Int, vol.35, pp.766-770, 2009. ,
Emerging contaminants in the environment: risk-based analysis for better management, Chemosphere, vol.154, pp.350-357, 2006. ,
Spatially explicit prioritization of human antibiotics and antineoplastics in Europe, Environ Int, vol.51, pp.13-26, 2013. ,
Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data, Sci Total Environ, vol.442, pp.380-388, 2013. ,
Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain, Sci Total Environ, vol.444, pp.451-465, 2013. ,
Nanotechnology risk perceptions and communication: emerging technologies, emerging challenges, Risk Anal, vol.31, pp.1694-1700, 2011. ,
Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a mediumsized mediterranean catchment, Environ Sci Technol, vol.40, pp.5282-5288, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01978614
Prioritization and analysis of pharmaceuticals for human use contaminating the aquatic ecosystem in Italy, J Pharm Biomed Anal, vol.106, pp.71-78, 2015. ,
Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals, Sci Total Environ, vol.461, pp.302-316, 2013. ,
Drug residues and endocrine disruptors in drinking water: risk for humans?, Int J Hyg Environ Health, vol.214, pp.437-441, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00878471
Do concentrations of pharmaceuticals in sewage reflect prescription figures?, Springer Science & Business Media, vol.22, pp.9110-9118, 2007. ,
Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options, J Hydrol, vol.389, pp.416-428, 2010. ,
Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review, Sci Total Environ, vol.429, pp.123-155, 2012. ,
Removal of cytostatic drugs from aquatic environment: a review, Sci Total Environ, pp.281-298, 2013. ,